Biblio
Export 601 results:
Author Title Type [ Year
Filters: First Letter Of Keyword is D [Clear All Filters]
“Predictive factors for disease progression in patients with early-onset Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 85-91, 2016.
, “Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 3, pp. 765-78, 2016.
, “Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 50, no. 3, pp. 765-78, 2016.
, “Prognostic Significance of Mild Cognitive Impairment Subtypes for Dementia and Mortality: Data from the NEDICES Cohort.”, J Alzheimers Dis, vol. 50, no. 3, pp. 719-31, 2016.
, “Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.”, J Alzheimers Dis, vol. 50, no. 2, pp. 539-46, 2016.
, “Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1085-93, 2016.
, “Progression of Extrapyramidal Signs in Alzheimer's Disease: Clinical and Neuropathological Correlates.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1085-93, 2016.
, “Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.”, J Alzheimers Dis, vol. 49, no. 3, pp. 671-80, 2016.
, “Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.”, J Alzheimers Dis, vol. 49, no. 3, pp. 671-80, 2016.
, “Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.”, J Alzheimers Dis, vol. 49, no. 3, pp. 671-80, 2016.
, “Puerarin Ameliorates D-Galactose Induced Enhanced Hippocampal Neurogenesis and Tau Hyperphosphorylation in Rat Brain.”, J Alzheimers Dis, vol. 51, no. 2, pp. 605-17, 2016.
, “Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 45-62, 2016.
, “Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1209-24, 2016.
, “Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1209-24, 2016.
, “Resting-State Cardiac Workload is Related to Both Increased Neocortical Aggregation of Amyloid-β and Relative Impairments in Spatial Working Memory in Pre-Clinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 1, pp. 127-31, 2016.
, “Reversal of LTP-Like Cortical Plasticity in Alzheimer's Disease Patients with Tau-Related Faster Clinical Progression.”, J Alzheimers Dis, vol. 50, no. 2, pp. 605-16, 2016.
, “Risk of dementia in patients with celiac disease: a population-based cohort study.”, J Alzheimers Dis, vol. 49, no. 1, pp. 179-85, 2016.
, “Risk of dementia in patients with celiac disease: a population-based cohort study.”, J Alzheimers Dis, vol. 49, no. 1, pp. 179-85, 2016.
, “The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 531-45, 2016.
, “The Role of Ethnicity in Alzheimer's Disease: Findings From The C-PATH Online Data Repository.”, J Alzheimers Dis, vol. 51, no. 2, pp. 515-23, 2016.
, “Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study.”, J Alzheimers Dis, vol. 51, no. 1, pp. 15-9, 2016.
, “Salidroside, a Bioactive Compound of Rhodiola Rosea, Ameliorates Memory and Emotional Behavior in Adult Mice.”, J Alzheimers Dis, vol. 52, no. 1, pp. 65-75, 2016.
, “Salidroside, a Bioactive Compound of Rhodiola Rosea, Ameliorates Memory and Emotional Behavior in Adult Mice.”, J Alzheimers Dis, vol. 52, no. 1, pp. 65-75, 2016.
, “Salidroside, a Bioactive Compound of Rhodiola Rosea, Ameliorates Memory and Emotional Behavior in Adult Mice.”, J Alzheimers Dis, vol. 52, no. 1, pp. 65-75, 2016.
, “Screening for Mild Cognitive Impairment: Comparison of "MCI Specific" Screening Instruments.”, J Alzheimers Dis, vol. 51, no. 2, pp. 619-29, 2016.
,